Verificando…
Traducido automáticamente. Dosis y advertencias: consulta el original en inglés. Leer en inglés
Inicio / Registrado en Nigeria / Nonsovid Tablet

Nonsovid Tablet

NAFDAC Reg. No. C4-1195 Estupefaciente

Registrado en NAFDAC. Registro activoAs of 29 October 2026 · synced automatically from official sources.
Producto
Nonsovid Tablet
Número NAFDAC
C4-1195
Principio activo
Ofloxacin
Dosis
400 mg
Forma
Tablet
Fabricante
No Constan
Solicitante (titular)
Simpec Pharmaceutical Limited
Approved
10 Nov 2020
Estado
Inactive Ver en NAFDAC ↗
Registro válido hasta
9 Nov 2025
Alertas de la OMS
No se ha encontrado ninguno
Informes de la comunidad
Ninguno
Tiempos comprobados
0

Pero sobre el medicamento, Ofloxacin: uses, dosage and brands worldwide

Lo que encontramos

  • Nonsovid Tablet is on the NAFDAC register with an active registration (C4-1195). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generado automáticamente a partir del registro NAFDAC, QUIÉN alerta y los datos de la comunidad a partir de hoy. Este no es un consejo médico. Siga siempre a su médico o farmacéutico.

How to use Nonsovid Tablet

Lo que dice el prospecto oficial. Si te lo recetó un médico, sigue la receta. Si el prospecto de tu caja es distinto, manda el de tu caja.

Para quién es

Ofloxacin ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below:

Cómo tomarlo y con qué frecuencia
  • The recommended dosage regimen
  • For the treatment of bacterial conjunctivitis is: Days 1 and 2 Instill one to two drops every two to four hours in the affected eye(s)
  • Days 3 through 7 Instill one to two drops four times daily
  • The recommended dosage regimen
  • For the treatment of bacterial corneal ulcer is: Days 1 and 2 Instill one to two drops into the affected eye every 30 minutes, while awake
  • Awaken at approximately four and six hours after retiring and instill one to two drops
  • Days 3 through 7 to 9 Instill one to two drops hourly, while awake
  • Days 7 to 9 through treatment completion Instill one to two drops, four times daily
Infancia
  • Safety and effectiveness in infants below the age of one year have not been established
  • Quinolones, including ofloxacin, have been shown to cause arthropathy in immature animals after oral administration; however, topical ocular administration of ofloxacin to immature animals has not shown any arthropathy
  • There is no evidence that the ophthalmic dosage form of ofloxacin has any effect on weight bearing joints
Older adults

No overall differences in safety or effectiveness have been observed between elderly and younger patients.

While you are taking it
  • Avoid contaminating the applicator tip with material from the eye, fingers or other source
  • Systemic quinolones, including ofloxacin, have been associated with hypersensitivity reactions, even following a single dose
  • Discontinue use immediately and contact your physician at the first sign of a rash or allergic reaction
Talk to a doctor first if

Ofloxacin ophthalmic solution is contraindicated in patients with a history of hypersensitivity to ofloxacin, to other quinolones, or to any of the components in this medication (see WARNINGS ).

Medicines it may not mix with

Specific drug interaction studies have not been conducted with ofloxacin ophthalmic solution. However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.

Warnings

NOT FOR INJECTION. Ofloxacin ophthalmic solution should not be injected subconjunctivally, nor should it be introduced directly into the anterior chamber of the eye. There are rare reports of anaphylactic reaction/shock and fatal hypersensitivity reactions in patients receiving systemic quinolones, some following the first dose, including ofloxacin. Some reactions were accompanied by cardiovascular collapse, loss of consciousness, angioedema (including laryngeal, pharyngeal or facial edema), airway obstruction, dyspnea, urticaria, and itching. …

Posibles efectos secundarios

Ophthalmic use: The most frequently reported drug-related adverse reaction was transient ocular burning or discomfort. Other reported reactions include stinging, redness, itching, chemical conjunctivitis/keratitis, ocular/periocular/facial edema, foreign body sensation, photophobia, blurred vision, tearing, dryness, and eye pain. Rare reports of dizziness and nausea have been received. Refer to WARNINGS for additional adverse reactions. To report SUSPECTED ADVERSE REACTIONS, contact Sentlss at 1--855-473-6847 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Pregnancy and breastfeeding

Pregnancy: Teratogenic Effects: Ofloxacin has been shown to have an embryocidal effect in rats and in rabbits when given in doses of 810 mg/kg/day (equivalent to 9000 times the maximum recommended daily ophthalmic dose) and 160 mg/kg/day (equivalent to 1800 times the maximum recommended daily ophthalmic dose). These dosages resulted in decreased fetal body weight and increased fetal mortality in rats and rabbits, respectively. …

How to store it

STORAGE: Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Distributed by: Armas Pharmaceuticals, Inc. Freehold, NJ 07728 USA Manufactured by: Ophtapharm AG, Riethofstrasse 1, Hettlingen, 8442, Switzerland (CHE) for Sentiss Ma …

Si olvidas una dosis

Tómala en cuanto te acuerdes, salvo que falte poco para la siguiente. En ese caso, sáltate la olvidada. Nunca tomes dos dosis a la vez para compensar. Revisa tu prospecto, porque algunos medicamentos son distintos.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2023-10-23.

Label for ofloxacin, the active ingredient registered with NAFDAC.

Check your pack of Nonsovid Tablet

Add the expiry date on your pack for a full Trust Score.

O haz fotos de la caja
Te quedan 3 verificaciones gratis hoy Fuentes oficiales: FDA de EE. UU. · EMA (UE) · NAFDAC · alertas de la OMS

About Nonsovid Tablet

What is in Nonsovid Tablet?

Nonsovid Tablet contains Ofloxacin (400 mg), as tablet, according to its NAFDAC registration record.

Is Nonsovid Tablet registered with NAFDAC?

Yes. Nonsovid Tablet is listed on the NAFDAC register under registration number C4-1195, and its registration is active as of 29 October 2026.

Has Nonsovid Tablet been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Nonsovid Tablet in our automatically synced alert list.

How can I check that my pack of Nonsovid Tablet is genuine?

Run a free authenticity scan with the NAFDAC number C4-1195, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Nonsovid Tablet?

Follow your prescription or the leaflet in your pack. The official label says: The recommended dosage regimen for the treatment of bacterial conjunctivitis is: Days 1 and 2 Instill one to two drops every two to four hours in the affected eye(s). Days 3 through 7 Instill one to two drops four times daily. The recommended dosage regimen for the treatment of bacterial corneal ulcer is: Days 1 and 2 Instill one to two drops into the affected eye every 30 minu…

What is Nonsovid Tablet used for?

Ofloxacin ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below: (Summarised from the official U.S. FDA label for ofloxacin. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Nonsovid Tablet? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.